This report aims to provide a comprehensive presentation of the global market for Orphan Drugs for Adults, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orphan Drugs for Adults. This report contains market size and forecasts of Orphan Drugs for Adults in global, including the following market information:
Global Orphan Drugs for Adults Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Orphan Drugs for Adults market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Oncology Drugs Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Orphan Drugs for Adults include Abbvie Inc., Orpharma, Amgen Inc., Recordati SpA, Novartis, Celgene, Amryt Pharma Plc., Johnson & Johnson and GSK Plc., etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Orphan Drugs for Adults companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Orphan Drugs for Adults Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Orphan Drugs for Adults Market Segment Percentages, by Type, 2022 (%)
Oncology Drugs
Gastrointestinal Drugs
Neurology Drugs
Cardio-vascular Drugs
Others
Global Orphan Drugs for Adults Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Orphan Drugs for Adults Market Segment Percentages, by Application, 2022 (%)
Hospital Pharmacies
Retail pharmacies
Others
Global Orphan Drugs for Adults Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Orphan Drugs for Adults Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Orphan Drugs for Adults revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Orphan Drugs for Adults revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbvie Inc.
Orpharma
Amgen Inc.
Recordati SpA
Novartis
Celgene
Amryt Pharma Plc.
Johnson & Johnson
GSK Plc.
Bristol-Myers Squibb Company
Roche Holding
Sanofi
Takeda
Pfizer
Vertex Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orphan Drugs for Adults, market overview.
Chapter 2: Global Orphan Drugs for Adults market size in revenue.
Chapter 3: Detailed analysis of Orphan Drugs for Adults company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orphan Drugs for Adults in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Orphan Drugs for Adults Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Orphan Drugs for Adults Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Orphan Drugs for Adults Overall Market Size
2.1 Global Orphan Drugs for Adults Market Size: 2022 VS 2030
2.2 Global Orphan Drugs for Adults Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Orphan Drugs for Adults Players in Global Market
3.2 Top Global Orphan Drugs for Adults Companies Ranked by Revenue
3.3 Global Orphan Drugs for Adults Revenue by Companies
3.4 Top 3 and Top 5 Orphan Drugs for Adults Companies in Global Market, by Revenue in 2022
3.5 Global Companies Orphan Drugs for Adults Product Type
3.6 Tier 1, Tier 2 and Tier 3 Orphan Drugs for Adults Players in Global Market
3.6.1 List of Global Tier 1 Orphan Drugs for Adults Companies
3.6.2 List of Global Tier 2 and Tier 3 Orphan Drugs for Adults Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Orphan Drugs for Adults Market Size Markets, 2022 & 2030
4.1.2 Oncology Drugs
4.1.3 Gastrointestinal Drugs
4.1.4 Neurology Drugs
4.1.5 Cardio-vascular Drugs
4.1.6 Others
4.2 By Type - Global Orphan Drugs for Adults Revenue & Forecasts
4.2.1 By Type - Global Orphan Drugs for Adults Revenue, 2018-2023
4.2.2 By Type - Global Orphan Drugs for Adults Revenue, 2024-2030
4.2.3 By Type - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Orphan Drugs for Adults Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail pharmacies
5.1.4 Others
5.2 By Application - Global Orphan Drugs for Adults Revenue & Forecasts
5.2.1 By Application - Global Orphan Drugs for Adults Revenue, 2018-2023
5.2.2 By Application - Global Orphan Drugs for Adults Revenue, 2024-2030
5.2.3 By Application - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Orphan Drugs for Adults Market Size, 2022 & 2030
6.2 By Region - Global Orphan Drugs for Adults Revenue & Forecasts
6.2.1 By Region - Global Orphan Drugs for Adults Revenue, 2018-2023
6.2.2 By Region - Global Orphan Drugs for Adults Revenue, 2024-2030
6.2.3 By Region - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Orphan Drugs for Adults Revenue, 2018-2030
6.3.2 US Orphan Drugs for Adults Market Size, 2018-2030
6.3.3 Canada Orphan Drugs for Adults Market Size, 2018-2030
6.3.4 Mexico Orphan Drugs for Adults Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Orphan Drugs for Adults Revenue, 2018-2030
6.4.2 Germany Orphan Drugs for Adults Market Size, 2018-2030
6.4.3 France Orphan Drugs for Adults Market Size, 2018-2030
6.4.4 U.K. Orphan Drugs for Adults Market Size, 2018-2030
6.4.5 Italy Orphan Drugs for Adults Market Size, 2018-2030
6.4.6 Russia Orphan Drugs for Adults Market Size, 2018-2030
6.4.7 Nordic Countries Orphan Drugs for Adults Market Size, 2018-2030
6.4.8 Benelux Orphan Drugs for Adults Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Orphan Drugs for Adults Revenue, 2018-2030
6.5.2 China Orphan Drugs for Adults Market Size, 2018-2030
6.5.3 Japan Orphan Drugs for Adults Market Size, 2018-2030
6.5.4 South Korea Orphan Drugs for Adults Market Size, 2018-2030
6.5.5 Southeast Asia Orphan Drugs for Adults Market Size, 2018-2030
6.5.6 India Orphan Drugs for Adults Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Orphan Drugs for Adults Revenue, 2018-2030
6.6.2 Brazil Orphan Drugs for Adults Market Size, 2018-2030
6.6.3 Argentina Orphan Drugs for Adults Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Orphan Drugs for Adults Revenue, 2018-2030
6.7.2 Turkey Orphan Drugs for Adults Market Size, 2018-2030
6.7.3 Israel Orphan Drugs for Adults Market Size, 2018-2030
6.7.4 Saudi Arabia Orphan Drugs for Adults Market Size, 2018-2030
6.7.5 UAE Orphan Drugs for Adults Market Size, 2018-2030
7 Orphan Drugs for Adults Companies Profiles
7.1 Abbvie Inc.
7.1.1 Abbvie Inc. Company Summary
7.1.2 Abbvie Inc. Business Overview
7.1.3 Abbvie Inc. Orphan Drugs for Adults Major Product Offerings
7.1.4 Abbvie Inc. Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.1.5 Abbvie Inc. Key News & Latest Developments
7.2 Orpharma
7.2.1 Orpharma Company Summary
7.2.2 Orpharma Business Overview
7.2.3 Orpharma Orphan Drugs for Adults Major Product Offerings
7.2.4 Orpharma Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.2.5 Orpharma Key News & Latest Developments
7.3 Amgen Inc.
7.3.1 Amgen Inc. Company Summary
7.3.2 Amgen Inc. Business Overview
7.3.3 Amgen Inc. Orphan Drugs for Adults Major Product Offerings
7.3.4 Amgen Inc. Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.3.5 Amgen Inc. Key News & Latest Developments
7.4 Recordati SpA
7.4.1 Recordati SpA Company Summary
7.4.2 Recordati SpA Business Overview
7.4.3 Recordati SpA Orphan Drugs for Adults Major Product Offerings
7.4.4 Recordati SpA Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.4.5 Recordati SpA Key News & Latest Developments
7.5 Novartis
7.5.1 Novartis Company Summary
7.5.2 Novartis Business Overview
7.5.3 Novartis Orphan Drugs for Adults Major Product Offerings
7.5.4 Novartis Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.5.5 Novartis Key News & Latest Developments
7.6 Celgene
7.6.1 Celgene Company Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene Orphan Drugs for Adults Major Product Offerings
7.6.4 Celgene Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.6.5 Celgene Key News & Latest Developments
7.7 Amryt Pharma Plc.
7.7.1 Amryt Pharma Plc. Company Summary
7.7.2 Amryt Pharma Plc. Business Overview
7.7.3 Amryt Pharma Plc. Orphan Drugs for Adults Major Product Offerings
7.7.4 Amryt Pharma Plc. Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.7.5 Amryt Pharma Plc. Key News & Latest Developments
7.8 Johnson & Johnson
7.8.1 Johnson & Johnson Company Summary
7.8.2 Johnson & Johnson Business Overview
7.8.3 Johnson & Johnson Orphan Drugs for Adults Major Product Offerings
7.8.4 Johnson & Johnson Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.8.5 Johnson & Johnson Key News & Latest Developments
7.9 GSK Plc.
7.9.1 GSK Plc. Company Summary
7.9.2 GSK Plc. Business Overview
7.9.3 GSK Plc. Orphan Drugs for Adults Major Product Offerings
7.9.4 GSK Plc. Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.9.5 GSK Plc. Key News & Latest Developments
7.10 Bristol-Myers Squibb Company
7.10.1 Bristol-Myers Squibb Company Company Summary
7.10.2 Bristol-Myers Squibb Company Business Overview
7.10.3 Bristol-Myers Squibb Company Orphan Drugs for Adults Major Product Offerings
7.10.4 Bristol-Myers Squibb Company Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.10.5 Bristol-Myers Squibb Company Key News & Latest Developments
7.11 Roche Holding
7.11.1 Roche Holding Company Summary
7.11.2 Roche Holding Business Overview
7.11.3 Roche Holding Orphan Drugs for Adults Major Product Offerings
7.11.4 Roche Holding Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.11.5 Roche Holding Key News & Latest Developments
7.12 Sanofi
7.12.1 Sanofi Company Summary
7.12.2 Sanofi Business Overview
7.12.3 Sanofi Orphan Drugs for Adults Major Product Offerings
7.12.4 Sanofi Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.12.5 Sanofi Key News & Latest Developments
7.13 Takeda
7.13.1 Takeda Company Summary
7.13.2 Takeda Business Overview
7.13.3 Takeda Orphan Drugs for Adults Major Product Offerings
7.13.4 Takeda Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.13.5 Takeda Key News & Latest Developments
7.14 Pfizer
7.14.1 Pfizer Company Summary
7.14.2 Pfizer Business Overview
7.14.3 Pfizer Orphan Drugs for Adults Major Product Offerings
7.14.4 Pfizer Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.14.5 Pfizer Key News & Latest Developments
7.15 Vertex Pharmaceuticals
7.15.1 Vertex Pharmaceuticals Company Summary
7.15.2 Vertex Pharmaceuticals Business Overview
7.15.3 Vertex Pharmaceuticals Orphan Drugs for Adults Major Product Offerings
7.15.4 Vertex Pharmaceuticals Orphan Drugs for Adults Revenue in Global Market (2018-2023)
7.15.5 Vertex Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Orphan Drugs for Adults Market Opportunities & Trends in Global Market
Table 2. Orphan Drugs for Adults Market Drivers in Global Market
Table 3. Orphan Drugs for Adults Market Restraints in Global Market
Table 4. Key Players of Orphan Drugs for Adults in Global Market
Table 5. Top Orphan Drugs for Adults Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Orphan Drugs for Adults Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Orphan Drugs for Adults Revenue Share by Companies, 2018-2023
Table 8. Global Companies Orphan Drugs for Adults Product Type
Table 9. List of Global Tier 1 Orphan Drugs for Adults Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Orphan Drugs for Adults Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Orphan Drugs for Adults Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Orphan Drugs for Adults Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Orphan Drugs for Adults Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Orphan Drugs for Adults Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Orphan Drugs for Adults Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Orphan Drugs for Adults Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Orphan Drugs for Adults Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Orphan Drugs for Adults Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Orphan Drugs for Adults Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Orphan Drugs for Adults Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Orphan Drugs for Adults Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Orphan Drugs for Adults Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Orphan Drugs for Adults Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Orphan Drugs for Adults Revenue, (US$, Mn), 2024-2030
Table 30. Abbvie Inc. Company Summary
Table 31. Abbvie Inc. Orphan Drugs for Adults Product Offerings
Table 32. Abbvie Inc. Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 33. Abbvie Inc. Key News & Latest Developments
Table 34. Orpharma Company Summary
Table 35. Orpharma Orphan Drugs for Adults Product Offerings
Table 36. Orpharma Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 37. Orpharma Key News & Latest Developments
Table 38. Amgen Inc. Company Summary
Table 39. Amgen Inc. Orphan Drugs for Adults Product Offerings
Table 40. Amgen Inc. Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 41. Amgen Inc. Key News & Latest Developments
Table 42. Recordati SpA Company Summary
Table 43. Recordati SpA Orphan Drugs for Adults Product Offerings
Table 44. Recordati SpA Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 45. Recordati SpA Key News & Latest Developments
Table 46. Novartis Company Summary
Table 47. Novartis Orphan Drugs for Adults Product Offerings
Table 48. Novartis Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Celgene Company Summary
Table 51. Celgene Orphan Drugs for Adults Product Offerings
Table 52. Celgene Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 53. Celgene Key News & Latest Developments
Table 54. Amryt Pharma Plc. Company Summary
Table 55. Amryt Pharma Plc. Orphan Drugs for Adults Product Offerings
Table 56. Amryt Pharma Plc. Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 57. Amryt Pharma Plc. Key News & Latest Developments
Table 58. Johnson & Johnson Company Summary
Table 59. Johnson & Johnson Orphan Drugs for Adults Product Offerings
Table 60. Johnson & Johnson Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 61. Johnson & Johnson Key News & Latest Developments
Table 62. GSK Plc. Company Summary
Table 63. GSK Plc. Orphan Drugs for Adults Product Offerings
Table 64. GSK Plc. Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 65. GSK Plc. Key News & Latest Developments
Table 66. Bristol-Myers Squibb Company Company Summary
Table 67. Bristol-Myers Squibb Company Orphan Drugs for Adults Product Offerings
Table 68. Bristol-Myers Squibb Company Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 69. Bristol-Myers Squibb Company Key News & Latest Developments
Table 70. Roche Holding Company Summary
Table 71. Roche Holding Orphan Drugs for Adults Product Offerings
Table 72. Roche Holding Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 73. Roche Holding Key News & Latest Developments
Table 74. Sanofi Company Summary
Table 75. Sanofi Orphan Drugs for Adults Product Offerings
Table 76. Sanofi Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 77. Sanofi Key News & Latest Developments
Table 78. Takeda Company Summary
Table 79. Takeda Orphan Drugs for Adults Product Offerings
Table 80. Takeda Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 81. Takeda Key News & Latest Developments
Table 82. Pfizer Company Summary
Table 83. Pfizer Orphan Drugs for Adults Product Offerings
Table 84. Pfizer Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 85. Pfizer Key News & Latest Developments
Table 86. Vertex Pharmaceuticals Company Summary
Table 87. Vertex Pharmaceuticals Orphan Drugs for Adults Product Offerings
Table 88. Vertex Pharmaceuticals Orphan Drugs for Adults Revenue (US$, Mn) & (2018-2023)
Table 89. Vertex Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. Orphan Drugs for Adults Segment by Type in 2022
Figure 2. Orphan Drugs for Adults Segment by Application in 2022
Figure 3. Global Orphan Drugs for Adults Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Orphan Drugs for Adults Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Orphan Drugs for Adults Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Orphan Drugs for Adults Revenue in 2022
Figure 8. By Type - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 9. By Application - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 10. By Type - Global Orphan Drugs for Adults Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 12. By Application - Global Orphan Drugs for Adults Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 14. By Region - Global Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 15. By Country - North America Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 16. US Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 20. Germany Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 21. France Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 28. China Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 32. India Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 34. Brazil Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Orphan Drugs for Adults Revenue Market Share, 2018-2030
Figure 37. Turkey Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Orphan Drugs for Adults Revenue, (US$, Mn), 2018-2030
Figure 41. Abbvie Inc. Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Orpharma Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Amgen Inc. Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Recordati SpA Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Novartis Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Celgene Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Amryt Pharma Plc. Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Johnson & Johnson Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. GSK Plc. Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Bristol-Myers Squibb Company Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. Roche Holding Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Sanofi Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. Takeda Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Pfizer Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Vertex Pharmaceuticals Orphan Drugs for Adults Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
